Myungmoon stocks set fresh records

Shares of Myungmoon Pharm jumped from 3,820 won to 6,650 won between August 25 and 28, after the company reported its agreement with Pharmswell Bio which has a capacity to produce Tamiflu.

The company said the agreement is aimed at securing the raw materials of Tamiflu, when the Korean government takes a compulsory measure that stops the patent periods of Tamiflu and allows the domestic prod...